Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17
Pfizer
By Hugo Francisco de Souza Reviewed by Lily Ramsey, LLM Nov 12 2024 Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in children. Study: Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California . Image Credit: Billion Photos/Shutterstock.com A recent study in Vaccine analyzed public health data to assess the impact of COVID-19 vaccination on childhood multisystem inflammatory syndrome (MIS-
din zilele anterioare